• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1804350-38
Medical Device Problem Codes Leak/Splash (1354); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/01/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H6- device code 2017 clarifier: incorrect prep.Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event or Problem Description
It was reported that the procedure was to treat a lesion in the heavily calcified and mildly tortuous right coronary artery (rca).The 3.5x38mm xience skypoint stent delivery system (sds) was advanced to the lesion and once at the lesion site, the device was aspirated.After aspiration blood was observed in the unspecified inflation device [leak].As a result, the sds was removed without issue and the procedure was completed with a non-abbott device.There were no adverse patient effects reported, and no clinically significant delay reported.No additional information was provided.
 
Additional Manufacturer Narrative
The device was returned for analysis.The reported leak was not confirmed.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.It was reported that the xience skypoint stent delivery system (sds) was advanced to the lesion and once at the lesion site, the device was aspirated.It should be noted that the xience skypoint everolimus eluting coronary stent system instruction for use lists delivery system preparation steps to be performed prior to delivery procedure steps.If performed in this order a leak would have been identified prior to being used in a patient.It is unknown if the ifu deviation(s) directly caused or contributed to the reported event.The investigation was unable to determine a conclusive cause for the reported leak.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18159899
Report Number2024168-2023-12813
Device Sequence Number15069572
Product Code NIQ
UDI-Device Identifier08717648233449
UDI-Public08717648233449
Combination Product (Y/N)Y
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/08/2026
Device Catalogue Number1804350-38
Device Lot Number3061641
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 11/01/2023
Supplement Date Received by Manufacturer01/10/2024
Initial Report FDA Received Date11/17/2023
Supplement Report FDA Received Date01/19/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured06/09/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-